The Web is a huge and very promising source of medical drug leads. But, conventional search with generic search engines, does not really obtain novel discoveries. Inspired by the drug discovery approach, we add the idea of a "lead" to the search process. The resulting Lead-&-Search protocol avoids the trap of repeated fruitless search and is domain independent. The approach is applied in practice to drug leads in the Web. To serve as input to generic search engines, multi-dimensional chemical structures are linearized into strings, which are sliced into keyword components. Search results are reordered by novelty criteria relevant to drug discovery. Case studies demonstrate the approach: linearized components produce specific search outcomes, with low risk of semantic ambiguity, facilitating reordering and filtering of results.
INTRODUCTION
Development of new medical drugs, from initial concepts to commercial marketing, is an extremely long process. Any path to shorten it is of great value.
Often, new drug development starts from leadsmolecules with desirable activity -later improved by modifying groups of atoms (called fragments), to increase activity and decrease undesirable sideeffects. We use the term component for fragment.
The Web is a huge potential source of leads to new drugs. But, conventional search with a generic engine, rarely results in unexpected discoveries.
Inspired by medical drug development, we added the "lead" idea to the search process. One obtains a generic Lead-&-Search protocol, applicable to any Web discovery process, not just drugs.
The Lead-&-Search protocol alternates between lead proposal and search phases, as needed, thereby avoiding sterile repetitive search.
Our Web lead discovery approach is applied to novel drug development. Much of the information on potential drugs is multi-dimensional. This is an obstacle to generic search engines limited to linear keyword strings. We directly use linearized structures sliced into components as search inputs.
LEAD-&-SEARCH -THE PROTOCOL
Lead-&-Search is a completely generic protocol. Though inspired by new drug development from leads, it is applicable to any kind of Web discovery. The Lead-&-Search protocol goal is to overcome the problem of repeated fruitless search -analogous to a local minimum in an optimization problem -by random jumping to another lead. It aims to converge at successful discovery results, by alternate steps of proposing a lead and performing search.
The iterative Lead-&-Search process is schematically depicted in Figure 2 .1. Two spaces are involved: a semantic space containing potential leads -concepts used as inputs in a search engine working in a search space -and the search space containing result sets found in the Web.
The Lead-&-Search protocol starts from an initial lead (Lead-1 in Fig. 2.1) , as input to search. The protocol should be independent of the initial lead quality.
If search is fruitful, one may refine this Lead with the acquired knowledge. If search does not produce results as desired, one jumps to another lead (Lead-2) and retries search.
The Lead-&-Search loop is repeated until it is either successful or ends by a termination criterion. The Lead-&-Search protocol is detailed in Fig. 2 .2 in pseudo code. In order to apply the Lead-&-Search protocol in practice one needs: a) to set values to criteria (search-termination and leadtimeout); b) to determine algorithms to choose and refine a lead, perform search and random jumps. 
LEAD & SEARCH SOFTWARE ARCHITECTURE
The overall Lead & Search software architecture and behavior is schematically seen in Fig. 3 .1. A control unit makes decisions, depending on the software state and on current results. It decides whether to:
• Jump to another lead and perform search;
• Refine the drug-lead and repeat search;
• Terminate the whole process. The Lead-&-Search software system interacts with unmodified generic search engines. Search results are reordered and filtered by an analyzer module.
The drug-lead repository provides input to the search engine. Lead-&-Search success means:
1. The drug-lead is gradually refined; 2. New leads are discovered. 
SEARCH -WITH LINEARIZED STRUCTURES
Generic search engines are powerful, but only accept linear input strings. An important issue is which kinds of information can be effectively used in this way; see (Konyk, 2008) and (Searls, 2005) . Medical drugs are based on an active substance, represented by a molecule. There is a variety of knowledge types about a substance:
• Text -substance name and properties;
• Images -diverse physical spectra;
• 2-Dimensional (2-D) formula;
• 3-Dimensional (3-D) model. Text does not deserve special considerations. Spectral information images say, NMR (Nuclear Magnetic Resonance) see e.g. (Homans, 2004) , are too complex to serve as direct search inputs.
Molecular structures -2-D or 3-D -are graphs with edges connecting discrete entities (atoms or groups of atoms). They are amenable to linearized forms useful as search inputs.
SMILES is a "Simplified Molecular Input Line Entry" proposed by Weininger et al. (Weininger, 1988) , (Weininger, 1989) . It is an unambiguous string describing 2-D or 3-D structures. There is an open standard (OpenSMILES, 2007) .
SMILES is obtained by depth-first tree traversal of the molecule graph. The graph is trimmed (removing hydrogen atoms implicit by the graph skeleton); cycles are broken obtaining a spanning tree (numeric suffixes mark linked nodes of broken cycles). Parentheses mark tree branching points.
VALIDATION
Preliminary validation is provided by case studies with different types of physiological activity. Search with sliced linearized components obtains drugs and potential leads among the results.
Case Study 1: Vancomycin
Vancomycin is an antibiotic of molecular formula C 66 H 77 C l2 N 9 O 24 . Fig. 5 .1 displays its SMILES string (the bold [red] component is the search input). The corresponding 2-D structure is seen in Fig. 5 .2. Table 1 shows search results for three search engines (bing, google and yahoo). For the small result sets obtained (between 15 and 30 results) there are relatively many potential substances of interest. Result Set sizes: bing = 15; google = 28; yahoo = 30; Search rank format is: "engine name / numeric rank of result", say "bing/2".
Case Study 2: Midazolam
Midazolam, a hypnotic-sedative drug, has molecular formula C 18 H 13 ClFN 3. Fig. 5 .3 displays a SMILES string, corresponding to the 2-D structure in Fig. 5 .4. The component C2N1C3=C(C=C(C=C3)Cl) stressed in bold in Fig. 5 .3 served as search input. Results are seen in Table 2 for the same engines. The result sets (between 11 and 138 results) are still relatively small. The number of potential substances of interest is of the same order of magnitude. 
Case Study 3: Nelarabine
Nelarabine is a chemoterapy drug used to treat leukemia. Its molecular formula is C 11 H 15 N 5 O 5. Fig.   CC1=NC=C2N1C3=C (C=C(C=C3)Cl)C(=NC2)C4=CC= CC=C4F
CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6 =C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=
5.5 displays a SMILES string for this substance. Table 3 are manageable. The number of substances of interest is of the same order of magnitude. proportional relation between components' string size and result set size; d) direct search of drug names, say Vancomicyn, is too weak to be of value for discovery. The Lead notion has been used within a closed computational framework (Wise, 1983) and (Exman, 1988 ), but has not been yet applied to the Web.
Another linear molecular naming system is InChI (McNaught 2006) . SMILES is more readable than InChI, but conveys less information. Our choice of SMILES can be changed, if proved necessary.
In order to demonstrate the actual efficiency of the approach for drug discovery, an extensive investigation of a variety of drug families is needed.
Main Contribution
Our main contribution is the randomized "Lead" proposal phase added to "Search", forming the "Lead-&-Search" protocol, a powerful discovery mechanism in the Web
